share_log

Tiziana Life Sciences Doses First Patient With Intranasal Foralumab With Moderate Alzheimer's Disease

Tiziana Life Sciences Doses First Patient With Intranasal Foralumab With Moderate Alzheimer's Disease

Tiziana Life Sciences 对第一位中度阿尔茨海默病患者进行了鼻用Foralumab的给药
Benzinga ·  12/17 07:06

Tiziana Life Sciences Doses First Patient With Intranasal Foralumab With Moderate Alzheimer's Disease

Tiziana Life Sciences 对第一位中度阿尔茨海默病患者进行了鼻用Foralumab的给药

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发